Oppenheimer & Co’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,770
Closed -$266K 1501
2021
Q3
$266K Buy
2,770
+389
+16% +$42.5K 0.01% 1270
2021
Q2
$254K Sell
2,381
-511
-18% -$50.3K ﹤0.01% 1325
2021
Q1
$259K Buy
2,892
+451
+18% +$49.6K 0.01% 1246
2020
Q4
$245K Buy
+2,441
New +$182K 0.01% 1164

Other funds holding CRNC

Oppenheimer & Co's CRNC Position: Q4 2021 in Review

Oppenheimer & Co sold out of Cerence (CRNC) in Q4 2021, closing a stake of 2,770 shares — an estimated $266K sold.

Oppenheimer & Co first reported a position in CRNC in Q4 2020 and held it in 4 quarters. The position peaked at $266K in Q3 2021. 360 funds tracked by Wall St. Rank hold CRNC as of Q4 2021.

  • Oppenheimer & Co reported no remaining Cerence position as of Q4 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 2,770 Cerence shares in Q4 2021, an estimated $266K.
  • Oppenheimer & Co first reported a position in Cerence in Q4 2020 and held it in 4 quarters.
  • Oppenheimer & Co's Cerence position peaked at $266K in Q3 2021.
  • 360 funds tracked by Wall St. Rank held Cerence as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.